Research Articles
Zapping Cancer with Gold Nanorods: A Precision Strike Against Tumors
Explore how aptamer-conjugated gold nanorods offer precise cancer treatment by targeting EGFR-overexpressed tumors with minimal side effects.
Taming the Explosion: How Calming Cellular Detonations Could Slow Cancer's Spread
Discover how minimizing explosive cell death could slow inflammation and prevent cancer metastasis through groundbreaking cellular research.
Stopping Cancer in Its Tracks: The Hunt for RON Receptor Inhibitors
Exploring the computational discovery of RON receptor tyrosine kinase inhibitors as promising targeted cancer therapies
Breaking the Chain: How Scientists are Retooling Cancer Drugs to Combat Deadly Blood Clots
Discover how Greek scientists are redesigning tyrosine kinase inhibitors to create dual-purpose medications that fight cancer and prevent dangerous blood clots.
The Unlikely Villain: How a Seemingly Harmless Implant Can Spur Cancer
Explore the fascinating phenomenon of foreign-body carcinogenesis, where chemically inert materials can trigger cancer through physical shape and chronic inflammation.
The Cancer Link: Unmasking Hidden Risks for Muscle Disease Patients
Understanding the increased cancer risk in patients with idiopathic inflammatory myopathies and the screening strategies that could save lives.
The Master Key: How a New Smart Bomb for Cancer Leaves Healthy Cells Unharmed
Discover how a new irreversible HER2 inhibitor acts as a precision weapon against cancer cells while sparing healthy tissue
Nature's Blueprint: The Hunt for the Next Generation of Cancer Medicines
Explore how scientists are redesigning natural products to create more effective anticancer drugs through molecular architecture and cutting-edge research.
The Molecular Showdown: How a Tiny Chemical Change is Revolutionizing the Fight Against Cancer
Discover how click chemistry creates more effective cancer drug conjugates than traditional esterification methods.
Disrupting Cancer's Fuel Line: The Hunt for a New Weapon
Exploring how triazole-substituted N-hydroxyindol-2-carboxylates inhibit hLDH5 to disrupt cancer metabolism